10mg/ml tirzepatide BPI - 3ml vial MOUNJARO 10 MG / 0.5

Some vendors require specific credentials to make the purchase or require you to check a box saying your purchase is for research purposes only and not intended for human and animal use, while others include similar language on each peptide product page

Tirzepatide tends to be the better choice if: You have a higher starting BMI (say, above 35) and want maximum weight loss You also have type 2 diabetes and need stronger glycemic control You've tried semaglutide and plateaued before reaching your goal Cost is similar for you (LillyDirect direct-pay vials currently undercut Wegovy on entry tiers) Semaglutide tends to be the better choice if: You have established cardiovascular disease and want a drug with proven CV outcome benefit (SELECT) [9] You tolerated 1 mg Ozempic well in the past and your insurance covers Wegovy You prefer the longer real-world track record (Wegovy approved 2021 versus Zepbound 2023) You need an oral option (Rybelsus, though it's FDA-approved for diabetes, not weight loss) Either is reasonable if: You're starting from BMI 30 to 35 with no major comorbidities Your insurance pushes you toward one over the other You're in the early titration period and haven't yet seen what your response looks like A real-world example

Tirzepatide reduces systemic inflammation, improves endothelial function, and enhances blood flow to all organs and tissues

Its that hunger and appetite consistently override their best intentions

Shop Customer Favorites Best-selling vitamins & supplements Shop Customer Favorites

Monitoring and documentation: Monitor the lump and note any changes over time